Tymora Analytical Operations
PrivateLast Round
Grant
Oct 8, 2019
Total Funding Raised
$2.89M
Company Overview
Tymora Analytical Operations operates in Healthcare & Life Sciences and is based in West Lafayette, Indiana. Its latest recorded funding round was a Grant round in October 2019.
Tymora Analytical Operations is a life sciences company that develops nanotechnology-based tools and provides contract services for protein analysis, biomarker discovery, and exosome research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tymora Analytical Operations Comparables
Compare Tymora Analytical Operations with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ProtiFi | 78% | |
| INOVIQ Ltd | 77% | |
| CellBio Scientific | 77% |
For institutional investors. Book with your work email.
Tymora Analytical Operations Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 8, 2019 | ||||
| Grant | Sep 10, 2019 | ||||
| Grant | Jul 28, 2015 | ||||
| Grant | Oct 15, 2014 | ||||
| Grant | Feb 28, 2013 | ||||
Grant | Nov 16, 2012 |
For institutional investors. Book with your work email.
Tymora Analytical Operations Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Purdue Research Foundation | Seed |
| National Institute on Aging | Grant |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| National Institutes of Health (NIH) | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 11, 2026
Monthly visitors increased 32% MoM, reaching 2K.
- May 4, 2025
Monthly visitors grew 103% MoM, reaching 1.1K.
For institutional investors. Book with your work email.
Tymora Analytical Operations Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Tymora Analytical Operations's valuation, stock price, and market status.
Is Tymora Analytical Operations a public or private company?
Tymora Analytical Operations is a private company.
What is the current stock price of Tymora Analytical Operations?
Tymora Analytical Operations is a private company, so its shares have no public market price. Caplight tracks Tymora Analytical Operations's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Tymora Analytical Operations worth (valuation)?
Valuation information for Tymora Analytical Operations is not publicly available.
Can I buy Tymora Analytical Operations stock?
Tymora Analytical Operations shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Tymora Analytical Operations's last funding round?
Tymora Analytical Operations's most recent funding round was Grant on October 8, 2019.
Who are the main investors in Tymora Analytical Operations?
Key investors in Tymora Analytical Operations include National Cancer Institute, Purdue Research Foundation, National Institute on Aging, The Michael J. Fox Foundation for Parkinson's Research, National Institutes of Health (NIH).
Will Tymora Analytical Operations IPO soon?
No public IPO plans have been announced for Tymora Analytical Operations.
How can I track Tymora Analytical Operations secondary market activity?
Caplight tracks bids, offers, and trades in Tymora Analytical Operations's shares on secondary markets.